Team
Denboba Lab
Group Leader Ayele Argaw Denboba
Ayele Argaw Denboba studied at the University of Addis Ababa in Ethiopia. He completed his PhD at the University of Rome Tor Vergata in Italy with a project investigating the role of retrotransposons in cancer progression.
From 2015, he was a postdoctoral research associate at the University of Rome Tor Vergata and then became a fellow in the international flagship postdoctoral program EI3POD at the European Molecular Biology Laboratory (EMBL) in Rome, Italy, in collaboration with EMBL Heidelberg, Germany. His postdoctoral research focused on gut microbiota-germline interactions.
Since August 2023, Ayele Argaw Denboba has been leading the research group on “Microbiome-Epigenome Axis in Early Life Programming” at the MPI of Immunobiology and Epigenetics in Freiburg (MPI-IE), Germany.
Qualifications and history
-
Born in Ethiopia
Undergraduate studies in Clinical laboratory science, and tropical and infectious disease at Addis Ababa University, Ethiopia. - 2012–2014 PhD studies at the University of Rome Tor Vergata, Italy
- 2015–2017 Postdoctoral research associate at the University of Rome Tor Vergata, Italy
- 2018–2023 EIPOD postdoctoral fellow co-funded by European Molecular Biology Laboratory (EMBL) and European Union’s Horizon 2020 research and innovation programme under Marie Skłodowska Curie Actions
- Since 2023 Group leader at the Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Team
- 551
- 556
- 550
- 721
- 551
- 556
- 551
- 556
- 551
- 556